Fate Therapeutics, Inc. (FRA:F6T)

Fate Therapeutics Statistics

Total Valuation

FRA:F6T has a market cap or net worth of EUR 115.54 million. The enterprise value is 921,007.

Market Cap	115.54M
Enterprise Value	921,007

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	115.35M
Shares Outstanding	n/a
Shares Change (YoY)	+8.77%
Shares Change (QoQ)	+0.40%
Owned by Insiders (%)	1.46%
Owned by Institutions (%)	62.96%
Float	100.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.99
PB Ratio	0.58
P/TBV Ratio	0.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.01
EV / Sales	0.15
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.01

Financial Position

The company has a current ratio of 7.87, with a Debt / Equity ratio of 0.34.

Current Ratio	7.87
Quick Ratio	7.74
Debt / Equity	0.34
Debt / EBITDA	n/a
Debt / FCF	-0.69
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -52.35% and return on invested capital (ROIC) is -25.82%.

Return on Equity (ROE)	-52.35%
Return on Assets (ROA)	-23.85%
Return on Invested Capital (ROIC)	-25.82%
Return on Capital Employed (ROCE)	-50.70%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	33,607
Profits Per Employee	-735,022
Employee Count	181
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-25.67%
50-Day Moving Average	0.90
200-Day Moving Average	0.97
Relative Strength Index (RSI)	50.19
Average Volume (20 Days)	262

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.26

Income Statement

In the last 12 months, FRA:F6T had revenue of EUR 6.08 million and -133.04 million in losses. Loss per share was -1.12.

Revenue	6.08M
Gross Profit	-78.76M
Operating Income	-136.36M
Pretax Income	-133.04M
Net Income	-133.04M
EBITDA	-123.88M
EBIT	-136.36M
Loss Per Share	-1.12

Balance Sheet

The company has 183.61 million in cash and 67.54 million in debt, with a net cash position of 116.06 million.

Cash & Cash Equivalents	183.61M
Total Debt	67.54M
Net Cash	116.06M
Net Cash Per Share	n/a
Equity (Book Value)	199.49M
Book Value Per Share	1.73
Working Capital	164.61M

Cash Flow

In the last 12 months, operating cash flow was -94.24 million and capital expenditures -4.14 million, giving a free cash flow of -98.38 million.

Operating Cash Flow	-94.24M
Capital Expenditures	-4.14M
Free Cash Flow	-98.38M
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-2,241.75%
Pretax Margin	-2,187.11%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:F6T does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.77%
Shareholder Yield	-8.77%
Earnings Yield	-115.15%
FCF Yield	-85.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:F6T has an Altman Z-Score of -6.02 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.02
Piotroski F-Score	1